SCHEMBL1860615

SCHEMBL1860615

COC(=O)C1CC(C(=O)OC)C(C(=O)OC)C1C(=O)OC

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 1/20 0.42
▸ CHRM4 P08173 1/20 0.42
▸ CHRM3 P20309 1/20 0.42
▸ PPM1B O75688 1/20 0.42
▸ PTPN1 P18031 1/20 0.42
▸ PPP1CC P36873 1/20 0.42
▸ CHRNB2 P17787 2/20 0.40
▸ CHRNA4 P43681 2/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ CHRNB4 P30926 1/20 0.40
▸ CHRNA3 P32297 1/20 0.40
▸ CHRNA7 P36544 1/20 0.40
▸ CYP3A4 P08684 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2699295 1.00 CHRM2 (0.42) CHRM2CHRM4CHRM3PPM1BPTPN1
SCHEMBL15644597 1.00 CHRM2 (0.42) CHRM2CHRM4CHRM3PPM1BPTPN1
SCHEMBL2701193 1.00 CHRM2 (0.42) CHRM2CHRM4CHRM3PPM1BPTPN1
SCHEMBL22061911 0.90 CHRM2 (0.47) CHRM2CHRM4CHRM3PPM1BPTPN1
SCHEMBL1298159 0.89 CHRM2 (0.48) CHRM2CHRM4CHRM3CHRNB2CHRNA4
SCHEMBL8494369 0.89 CHRM2 (0.48) CHRM2CHRM4CHRM3CHRNB2CHRNA4
SCHEMBL31285391 0.89 CHRM2 (0.48) CHRM2CHRM4CHRM3CHRNB2CHRNA4
SCHEMBL974400 0.89 CHRM2 (0.48) CHRM2CHRM4CHRM3CHRNB2CHRNA4
SCHEMBL974399 0.89 CHRM2 (0.48) CHRM2CHRM4CHRM3CHRNB2CHRNA4
SCHEMBL974796 0.89 CHRM2 (0.48) CHRM2CHRM4CHRM3CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3894477-B1 CONTROLLED CURE FOR COMPOSITIONS COMPRISING ACETOACETYLATED RESINS EASTMAN CHEM CO (US) 2025-01-15 — — EP disclosed
EP-3894475-B1 ASSEMBLY COMPONENTS COMPRISING CURABLE COMPOSITIONS CONTAINING ACETOACETYLATED RESINS EASTMAN CHEM CO (US) 2024-06-19 — — EP disclosed
EP-3894473-B1 CURABLE ACETOACETYLATED RESIN COMPOSITIONS AND ADDITIVES COMPRISING ADHESION PROMOTERS, GREEN STRENGTH ENHANCERS, OR COMBINATIONS THEREOF EASTMAN CHEM CO (US) 2024-06-12 — — EP disclosed
US-11820923-B2 Controlled cure for compositions comprising acetoacetylated resins EASTMAN CHEMICAL COMPANY (US) 2023-11-21 — — US disclosed
CN-113195633-B Curable compositions comprising acetoacetylated resin, aldehyde, and certain amines 伊士曼化工公司 2023-11-07 — — CN disclosed
CN-113195635-B Curable acetoacetylated resin composition and additive comprising adhesion promoter, initial strength enhancer, or combination thereof 伊士曼化工公司 2023-10-10 — — CN disclosed
EP-3894474-B1 CURABLE COMPOSITIONS COMPRISING ACETOACETYLATED RESINS, ALDEHYDES AND CERTAIN AMINES EASTMAN CHEM CO (US) 2023-09-13 — — EP disclosed
CN-113260673-B Assembly comprising a curable composition comprising an acetoacetylated resin 伊士曼化工公司 2023-08-08 — — CN disclosed
CN-113195632-B Controlled curing of compositions comprising acetoacetylated resins 伊士曼化工公司 2023-07-14 — — CN disclosed
CN-113195634-B Flexible substrate comprising curable composition comprising acetoacetylated resin 伊士曼化工公司 2023-06-16 — — CN disclosed
WO-2008119688-A1 PHOTOACTIVABLE NITROGEN BASES BASF SE (CH) 2008-10-09 — — WO disclosed
EP-1796745-A2 POLYMER-BASED TISSUE-ADHESIVE FOR MEDICAL USE E.I.Du pont de nemours and company (US) 2007-06-20 — — EP disclosed
US-20070048337-A1 Aldol-crosslinked polymeric hydrogel adhesives ACTAMAX SURGICAL MATERIALS, LLC 2007-03-01 — — US disclosed
US-20070048251-A1 Methods for sealing an orifice in tissue using an aldol-crosslinked polymeric hydrogel adhesive ACTAMAX SURGICAL MATERIALS, LLC 2007-03-01 — — US disclosed
WO-2006042169-A2 POLYMER-BASED TISSUE-ADHESIVE FOR MEDICAL USE E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-04-20 — — WO disclosed
US-20060079599-A1 Polymer-based tissue-adhesive form medical use ACTAMAX SURGICAL MATERIALS, LLC 2006-04-13 — — US disclosed
US-5817777-A SEQUESTERING AMERSHAM INTERNATIONAL PLC (GB) 1998-10-06 — — US disclosed
EP-0668855-B1 SUBSTITUTED CYCLOPENTANE COMPOUNDS FOR USE AS CHELATING AGENTS AMERSHAM INT PLC (GB) 1998-06-24 — — EP disclosed
EP-0668855-A1 SUBSTITUTED CYCLOPENTANE COMPOUNDS FOR USE AS CHELATING AGENTS AMERSHAM INTERNATIONAL plc (GB) 1995-08-30 — — EP disclosed
WO-1994011339-A1 SUBSTITUTED CYCLOPENTANE COMPOUNDS FOR USE AS CHELATING AGENTS AMERSHAM INTERNATIONAL PLC (GB) 1994-05-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079599-A1 Polymer-based tissue-adhesive form medical use ADSL, SI, VCAM1 CHRM2 3663/4885CHRM4 3556/4885CHRM3 3231/4885
US-20070048337-A1 Aldol-crosslinked polymeric hydrogel adhesives ALDOA, ADSL, ALDH1A2 CHRM2 1492/4885CHRM4 1849/4885CHRM3 1519/4885
US-20070048251-A1 Methods for sealing an orifice in tissue using an aldol-crosslinked polymeric hydrogel adhesive SI, ADSL, AOX1 CHRM2 2875/4885CHRM4 2655/4885CHRM3 2301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback